Mogi-131 -

MOGI-131 is a potent, selective, and brain-penetrant GPR139 agonist with robust preclinical efficacy in depression, nicotine withdrawal, and motivational deficits. Its favorable pharmacokinetics and safety profile support progression toward first-in-human studies. As a tool compound, it will enable critical mechanistic dissection of GPR139’s role in reward, aversion, and mood regulation.

The term "mogi-131" has been circulating in scientific communities, particularly in the field of seismology. While the term might not be widely recognized, it appears to be linked to a specific type of seismic event or a model used to study seismic activity. mogi-131

With more context, I'll do my best to create an engaging and informative article about "mogi-131." MOGI-131 is a potent, selective, and brain-penetrant GPR139